CTOs on the Move

Southwest Center

www.swcenter.org

 
Southwest Center is a leader in providing HIV/AIDS services in Phoenix, AZ, including: HIV and STD testing, LGBTQ-friendly medical care, PrEP & PEP, community outreach, case management, behavioral health, empowerment programs, nutrition servic...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.swcenter.org
  • 1101, North Central Avenue
    Phoenix, AZ USA 85004
  • Phone: 602.307.5330

Executives

Name Title Contact Details

Similar Companies

Invuity

Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. The company`s patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA.

Capitol Drugs

Capitol Drugs is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sherman Oaks, CA. To find more information about Capitol Drugs, please visit www.capitoldrugs.com

Med-Trans Corporation

Med-Trans Corporation is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

National Surgical Hospitals

National Surgical Hospitals is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. National Surgical Hospitals is based in Chicago, IL. You can find more information on National Surgical Hospitals at www.nshinc.com

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.